Premier edition on PDA gives busy oncology practitioners fast access to the most current information on commonly prescribed oncology drugs and regimens-and the supportive therapies needed to manage the patient's disease and drug side effects. Full-length monographs, organized alphabetically, for more than 150 generic oncology drugs including 40 commonly used supportive-care drugs The latest FDA-approved indications-plus the most common off-label uses (with dosages) When and how to modify dosages based on patient condition and response FDA "black-box" warnings and common and life-threatening adverse reactions Interactions with other drugs, diagnostic tests, foods, and herbs Step-by-step drug preparation and administration protocols Special section on more than 180 common chemotherapy regimens used in major cancer centers, organized by cancer-type, plus supportive therapy necessitated by each regimen
This premier edition gives busy oncology practitioners fast access to the most current information on all commonly prescribed oncology drugs and regimens-plus the supportive therapies needed to manage side effects. Created by oncology experts, this remarkable reference presents accurate, comprehensive, unbiased prescribing data in clear, concise language in a format tailored to meet oncology specialists' needs. Full-length monographs, organized alphabetically, for more than 150 generic oncology drugs including 40 commonly used supportive-care drugs The latest FDA-approved indications-plus the most common off-label uses (with dosages) When and how to modify dosages based on patient condition and response FDA "black-box" warnings and common and life-threatening adverse reactions Interactions with other drugs, diagnostic tests, foods, and herbs Step-by-step drug preparation and administration protocols Special section on more than 180 common chemotherapy regimens used in major cancer centers, organized by cancer-type, plus supportive therapy necessitated by each regimen
Today's patients have unique cardiologic needs before, during, and after cancer treatment. Chemotherapies, radiation therapy, and targeted therapies can produce acute side effects or lasting adverse consequences on the heart and circulatory system, making the field of cardio-oncology increasingly important in effective patient care. Cardio-Oncology Practice Manual is a comprehensive, portable guide that provides practical approaches to assessment and management of cardiovascular diseases due to the effects of cardiotoxic agents and treatments. Part of the Braunwald family of renowned cardiology references, it clearly presents clinically relevant aspects of this growing field in one quick, practical reference for a wide range of cardio-oncology providers. - Covers all major cancer therapies, cardiovascular toxicities, and malignancies in a portable, authoritative guide—ideal for cardiologists, cardio-oncologists, general practitioners, internists, medical oncologists, and hematologists. - Offers templated and streamlined content for quick retrieval, with key point summaries for each major section. - Presents cardiac disease entities and specific malignant diseases in a succinct overview format addressing important clinical care aspects. - Features "Central Illustrations" for each topic that visually summarize the chapter and its specific content including algorithms for management of cardiovascular toxicities and one-view overviews of malignancies. - Includes a comprehensive drug guide that provides quick reference to drugs prescribed for cancers with therapeutic indications, manifestations and mechanisms of cardiotoxicity, their risk factors, and risk reduction strategies. - Brings you up to date with new immune therapies, including immune checkpoint inhibitors and CAR T-cell therapies
**Selected for Doody's Core Titles® 2024 with "Essential Purchase" designation in Pharmacology**Find the essential information you need to safely administer more than 400 intravenous drugs! For nearly 50 years, Elsevier's Intravenous Medications: A Handbook for Nurses and Health Professionals has been a trusted resource for complete, accurate drug information in a concise, quick-access format. New to the 2025 edition are 16 monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings. - Detailed monographs on more than 400 IV drugs provide an impressive breadth of coverage that goes well beyond any comparable drug reference. - Individual monographs include the drug name, phonetic pronunciation, usual dose, dilution, compatibility, rate of administration, actions, indications and uses, contraindications, precautions, interactions, side effects, antidote, and more. - Additional drug monographs are provided on the Evolve website. - Highlighted Black Box Warnings make it easy to locate information on medications with serious safety risks. - Blue-screened text calls attention to special circumstances not covered by Black Box Warnings. - Dosage and dilution charts within monographs provide quick summaries of essential clinical information. - Life-stage dosage variances are highlighted for geriatric, pediatric, infant, and neonatal patients. - Convenient, A-to-Z format organizes all drug monographs by generic name, allowing you to find any drug in seconds. - Spiral binding allows the book to lie flat, leaving your hands free to perform other tasks. - NEW! Drug monographs for 16 newly approved drugs by the FDA include the most current information. - NEW! Updates on drug uses, interactions, precautions, alerts, and more are included throughout the guide to reflect changes to existing medications. - NEW! Best practices guidelines for the preparation and administration of injectable drugs are provided from the National Coalition for IV Push Safety.
- NEW! Drug monographs for 8 newly approved drugs by the FDA include the most current information. - NEW! Updates on drug uses, interactions, precautions, alerts, and more are included throughout the guide to reflect changes to existing medications. - NEW! Information on preparation and administration of injectable drugs from the National Coalition for IV Push Safety
Like getting 7 books in 1, MOSBY'S ONCOLOGY NURSING ADVISOR provides quick access to essential information on a wide range of cancer topics, including types of cancer, treatment options, symptom management, palliative care, and patient teaching. Its user-friendly layout and straightforward coverage make it ideal for use in any clinical setting, offering authoritative guidance to help you provide the best possible oncology nursing care. Detailed descriptions of over 50 major cancer types provide essential information on incidence, etiology and risk factors, signs and symptoms, diagnostic workup, histology, staging, treatment, prognosis, and prevention. Coverage of cancer management principles outlines a wide range of treatment and pharmacologic modalities, including surgery, chemotherapy, radiation therapy, hormonal therapy, biological response modifiers, and complementary and alternative therapies. Symptom management guidelines provide in-depth coverage of pathophysiology, assessment tools, lab and diagnostic tests, differential diagnoses, interventions, follow up care, and resources for over 30 common symptoms associated with cancer and cancer treatments. Essential information on many oncologic emergencies and emergent issues prepares you to respond quickly to structural, metabolic, and hematologic emergencies. Helpful patient teaching resources include more than 25 reproducible patient teaching handouts. An entire section on palliative care and end-of-life issues offers helpful guidelines for dealing with topics related to hospice care, communication in palliative care, the final hours of the cancer patient, ethical considerations, and loss, grief, and bereavement. Serves as a great study tool for the oncology nursing certification exam..
Approximately 175 pages, in a spiral or other handy pocket-type format (to be determined and agreed on.) Selected chemotherapy monographs, regimens and features from The Elsevier Guide to Oncology Drugs and Regimens print title in a shortened format, as appropriate for fitting.
Find the essential information you need to safely administer more than 400 intravenous drugs! For nearly 50 years, Elsevier’s Intravenous Medications: A Handbook for Nurses and Health Professionals has been a trusted resource for complete, accurate drug information in a concise, quick-access format. New to the 2023 edition are 10 monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings. Detailed monographs on more than 400 IV drugs provide an impressive breadth of coverage that goes well beyond any comparable drug reference. Individual monographs include the drug name, phonetic pronunciation, usual dose, dilution, compatibility, rate of administration, actions, indications and uses, contraindications, precautions, interactions, side effects, antidote, and more. Additional drug monographs are provided on the Evolve website. Highlighted Black Box Warnings make it easy to locate information on medications with serious safety risks. Blue-screened text calls attention to special circumstances not covered by Black Box Warnings. Dosage and dilution charts within monographs provide quick summaries of essential clinical information. Life-stage dosage variances are highlighted for geriatric, pediatric, infant, and neonatal patients. Convenient, A-to-Z format organizes all drug monographs by generic name, allowing students to find any drug in seconds. Spiral binding allows the book to lie flat, leaving the practitioner’s hands free to perform other tasks. NEW! Drug monographs for 10 newly approved drugs by the FDA include the most current information. NEW! Updates on drug uses, interactions, precautions, alerts, and more are included throughout the guide to reflect changes to existing medications.
Find the essential information you need to safely administer more than 400 intravenous drugs! For more than 45 years, Gahart’s Intravenous Medications: A Handbook for Nurses and Health Professionals has been a trusted resource for comprehensive drug coverage, unparalleled accuracy, and an intuitive quick-access format. In addition to updated drug interactions, precautions, alerts, and patient teaching instructions for all existing IV drugs, the 2022 edition includes approximately 10 new monographs of the most recent IV drugs to be approved by the FDA. Administering intravenous drugs is a critical task — inaccurate or out-of-date information is not an option. Known as the #1 IV drug handbook on the market, and with its history of impeccable accuracy, Gahart’s annual publication gives you the extra confidence and guidance you need to safely and effectively treat patients. Monographs on more than 400 IV drugs offer an impressive breadth of coverage that goes well beyond any comparable drug reference. Updated annual publication prevents you from referencing outdated information. Additional drug monographs are provided on the companion Evolve website. 45-year history of impeccable accuracy reinforces the importance of safe IV drug administration. Perfect depth of information equips you with everything that is needed for safe administration of IV drugs — nothing more, nothing less. Proven, clinically optimized format keeps all dosage information for each drug on either a single page or a two-page spread to prevent hand contamination by having to turn a page. Highlighted Black Box Warnings and relevant content make locating critical information fast and easy. Special circumstances in blue-screened text call attention to important circumstances that may not warrant Black Box Warnings. Life-stage dosage variances are highlighted for geriatric, pediatric, infant, and neonatal patients. Dilution and dosage charts within monographs provide quick access to essential clinical information. Convenient, alphabetical format organizes all drug monographs by generic name, allowing you to find any drug in seconds. NEW! Drug monographs for newly approved drugs by the FDA provide you with the most current drug information. Updates on drug interactions, precautions, alerts, and more have been made throughout the guide to reflect all changes to existing medications.
Animal Models in Cancer Drug Discovery brings forward the most cutting-edge developments in tumor model systems for translational cancer research. The reader can find under this one volume virtually all types of existing and emerging tumor models in use by the research community. This book provides a deeper insight on how these newer models could de-risk modern drug discovery. Areas covered include up to date information on latest organoid derived models and newer genetic models. Additionally, the book discusses humanized animal tumor models for cancer immunotherapy and how they leverage personalized therapies. The chapter on larger animal, canine models and their use in and their use in pre-investigational new drug (pre-IND) development makes the volume unique. Unlike before, the incorporation of several simplified protocols, breeding methodologies, handling and assessment procedures to study drug intervention makes this book a must read. Animal Models in Cancer Drug Discovery is a valuable resource for basic and translational cancer researchers, drug discovery researchers, contract research organizations, and knowledge seekers at all levels in the biomedical field.
